What packaging requirement is specified for products containing pseudoephedrine?

The packaging requirement specified for products containing pseudoephedrine is blister packs. This requirement is established to help enhance consumer safety and reduce the potential for misuse of pseudoephedrine, which is a precursor in the illegal manufacture of methamphetamine.

Blister packs provide several advantages in this context. First, they limit the number of units available at once, making it more difficult for individuals to acquire large quantities of pseudoephedrine in one purchase. Additionally, blister packs are usually tamper-resistant, which helps to ensure that the product remains unchanged from the time it is packaged until it is opened by the consumer. This reduces the risk of tampering and contamination and supports patient safety.

Other packaging formats such as bulk containers, pill bottles, or boxed packaging do not provide the same level of control and security needed to prevent the abuse of pseudoephedrine, which is why they are not suitable for this purpose. Using blister packs aligns with regulatory measures intended to manage access to certain substances while allowing consumers to access the medications they need safely.